Plasma concentrations of arginine and asymmetric dimethylarginine do not reflect their intracellular concentrations in peripheral blood mononuclear cells
Authors:
- Tom TeerlinkTTTom Teerlink
- 1 October 2013
- journal article
- Published by Elsevier in Metabolism
- Vol. 62 (10) , 1455-1461
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Low Serum Homoarginine Is a Novel Risk Factor for Fatal Strokes in Patients Undergoing Coronary AngiographyStroke, 2011
- Homoarginine, Cardiovascular Risk, and MortalityCirculation, 2010
- SDMA is an early marker of change in GFR after living-related kidney donationNephrology Dialysis Transplantation, 2010
- The Clinical Significance of Asymmetric DimethylarginineAnnual Review of Nutrition, 2006
- The discovery of nitric oxide and its role in vascular biologyBritish Journal of Pharmacology, 2006
- ADMA metabolism and clearanceVascular Medicine, 2005
- A Proteomic Analysis of Arginine-methylated Protein ComplexesMolecular & Cellular Proteomics, 2003
- Asymmetrical dimethylarginine (ADMA) in critically ill patients: high plasma ADMA concentration is an independent risk factor of ICU mortalityClinical Nutrition, 2003
- Plasma concentration of asymmetrical dimethylarginine and mortality in patients with end-stage renal disease: a prospective studyThe Lancet, 2001
- Asymmetric Dimethylarginine (ADMA): A Novel Risk Factor for Endothelial DysfunctionCirculation, 1998